BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 31415975)

  • 1. Generation of seven iPSC lines from peripheral blood mononuclear cells suitable to investigate Autism Spectrum Disorder.
    Bozaoglu K; Gao Y; Stanley E; Fanjul-Fernández M; Brown NJ; Pope K; Green CC; Vlahos K; Sourris K; Bahlo M; Delatycki M; Scheffer I; Lockhart PJ
    Stem Cell Res; 2019 Aug; 39():101516. PubMed ID: 31415975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an induced pluripotent stem cell line (KNIHi001-A) by reprogramming peripheral blood mononuclear cells isolated from a patient with Parkinson's disease.
    Baek D; Lee KG; Sohn HY; Park JH; Lee HK; Bayarsaikhan G; Yoo SW; Lee B; Kim JS; Koh YH; Kwon M
    Stem Cell Res; 2024 Apr; 76():103358. PubMed ID: 38447455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H1FOO-DD promotes efficiency and uniformity in reprogramming to naive pluripotency.
    Kunitomi A; Hirohata R; Osawa M; Washizu K; Arreola V; Saiki N; Kato TM; Nomura M; Kunitomi H; Ohkame T; Ohkame Y; Kawaguchi J; Hara H; Kusano K; Yamamoto T; Takashima Y; Tohyama S; Yuasa S; Fukuda K; Takasu N; Yamanaka S
    Stem Cell Reports; 2024 May; 19(5):710-728. PubMed ID: 38701780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of the Human iPSC Line from Spontaneous Late-Onset Alzheimer's Disease Patient with ApoE3/3 Genotype and Sex-, Age-, and ApoE-Matched Healthy Control.
    Kadakova S; Raska J; Hribkova H; Fedorova V; Sedmik J; Plesingrova K; Sheardova K; Bohaciakova D
    Stem Cell Res; 2024 Feb; 74():103273. PubMed ID: 38100913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of induced pluripotent stem cell line, NIMHi009-A, from PBMCs of an adult healthy male.
    Arunachal G; Milind Nimonkar M; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
    Stem Cell Res; 2024 Apr; 76():103349. PubMed ID: 38368738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of twenty four induced pluripotent stem cell lines from twenty four members of the Lothian Birth Cohort 1936.
    Toombs J; Panther L; Ornelas L; Liu C; Gomez E; Martín-Ibáñez R; Cox SR; Ritchie SJ; Harris SE; Taylor A; Redmond P; Russ TC; Murphy L; Cooper JD; Burr K; Selvaraj BT; Browne C; Svendsen CN; Cowley SA; Deary IJ; Chandran S; Spires-Jones TL; Sareen D
    Stem Cell Res; 2020 Jul; 46():101851. PubMed ID: 32450543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a human induced pluripotent stem cell line (OGIi001) from peripheral blood mononuclear cells of a healthy male donor.
    Zhang H; Daheron L; Cerna-Chavez R; Place EM; Huckfeldt RM; Pierce EA; Garita-Hernandez M
    Stem Cell Res; 2024 Feb; 74():103280. PubMed ID: 38134577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an induced pluripotent stem cell line (SDASi001-A) from a Schimke immune-osseous dysplasia patient with SMARCAL1 mutations.
    Wang X; Zhang H; Wang X; Zhou W; Dong L; Li N; He Q
    Stem Cell Res; 2023 Oct; 72():103217. PubMed ID: 37788557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of two induced pluripotent stem cell lines from two sporadic amyotrophic lateral sclerosis patients.
    Wen S; Fu S; Gao C; Lei K; Liu X
    Stem Cell Res; 2024 Feb; 74():103288. PubMed ID: 38181637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of human induced pluripotent stem cell lines derived from four patients with a pathogenic ALPK3 variant associated with adult-onset hypertrophic cardiomyopathy (HCM).
    Cheawsamoot C; Ramchandani R; Ameen M; Arthur Ataam J; Khongphatthanayothin A; Shotelersuk V; Karakikes I
    Stem Cell Res; 2023 Dec; 73():103233. PubMed ID: 37944352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of GMP-compliant iPSC lines generated by Sendai virus transduction is dependent upon clone identity and sex of the donor.
    Kuczynska Z; Neglur PK; Metin E; Liput M; Zychowicz M; Zayat V; Krześniak NE; Buzanska L; Kot M
    Folia Neuropathol; 2024; 62(1):32-46. PubMed ID: 38741435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic Characterization of a Chinese Family with Osteogenesis Imperfecta and Generation of Disease-Specific Induced Pluripotent Stem Cells.
    Li D; Ou M; Dai G; Zhu P; Luo Q; Chen J; Shah Z; Samokhvalov IM; Yin L; Sun G; Tang D; Dai Y
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):336. PubMed ID: 38179771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of iPSC lines derived from skin fibroblasts of two healthy controls using non-transmissible form of Sendai Virus.
    Orsi A; Serpieri V; Mazzotta C; Ramusino MC; Rossi E; Cerri S; Valente EM
    Stem Cell Res; 2024 Apr; 76():103332. PubMed ID: 38354648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Induced Pluripotent Stem Cell Production and Expansion from Blood using a Non-Integrating Viral Reprogramming Vector.
    Sharma A; Mücke M; Seidman CE
    Curr Protoc Mol Biol; 2018 Apr; 122(1):e58. PubMed ID: 29851250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of two induced pluripotent stem cell lines from healthy patients of African American ancestry.
    Mullen M; Kojic A; Alamana C; Canel G; Lai C; Knowles JW; Wu JC
    Stem Cell Res; 2024 Apr; 76():103322. PubMed ID: 38359472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of induced pluripotent stem cells from breast cancer patients carrying ATM mutations.
    Zhang M; Venkateshappa R; Li A; Fowler MB; Telli ML; Wu JC
    Stem Cell Res; 2023 Dec; 73():103246. PubMed ID: 37951143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a transgene-free iPS cell line (SDCHi003-A) from a young patient bearing a NPRL2 mutation and suffering from Epilepsy.
    Su S; Zhao F; Zhang H; Liu Y; Li Z; Zhang H; Wang Y; Fang F; Liu Y
    Stem Cell Res; 2024 Apr; 76():103366. PubMed ID: 38430737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a human induced pluripotent stem cell line (FDCHi012-A) from a patient with DYRK1A-related intellectual disability syndrome carrying DYRK1A mutation (c.1024G > T).
    Ge Y; Cheng Y; Yin T; Peng X; Xiong Z; Wu B; Wang H; Xiong M; Zhou W
    Stem Cell Res; 2024 Apr; 76():103345. PubMed ID: 38382213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient generation of induced pluripotent stem cell lines from healthy donors' peripheral blood mononuclear cells of different genders.
    Gao Y; Cheng Y; Lin B; Xiao D; Wen J; Xu J; Zheng R; Zhang M; Cai C; Hu J
    Stem Cell Res; 2024 Apr; 77():103421. PubMed ID: 38636268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of the iPS cell line (SYSUSHi001-A) derived from the peripheral blood mononuclear cells (PBMCs) of a 33-year-old patient with acute myeloid leukemia (AML).
    Yuan L; Xie M; Tao Y; Chen X; Xu X; Wang X
    Stem Cell Res; 2024 Feb; 77():103360. PubMed ID: 38608356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.